ORIC Pharmaceuticals

ORIC Pharmaceuticals Aktie

Investor Relations Website
WKN: A2P208
ISIN: US68622P1093
Marktkapitalisierung Help 973,46 Mio. $
Streubesitz 0%
KGV -5,56
Index-Zuordnung
-
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ORIC Pharmaceuticals, Inc.- ORIC Precision Killers: Why Big Pharma is Betting Billions to Beat a $170B Patent Cliff